Ravi Thakran’s Turmeric Capital said to consider Singapore SPAC listing
Tumeric Capital, the Singapore-based private equity firm led by former L Catterton Asia head Ravi Thakran, is said to be exploring listing a special purpose acquisition company (SPAC) in Singapore, according to a Bloomberg report ... The report said Turmeric capital is now working with advisers on the potential SPAC listing in Singapore even as the city-state has not rolled out its framework for blank-cheque listing ... According to a Business Times report, Thakran’s Turmeric Capital is among the three companies that are said to be exploring SPAC listings in Singapore.
Tumeric Capital, the Singapore-based private equity firm led by former L Catterton Asia head Ravi Thakran, is said to be exploring listing a special purpose acquisition company (SPAC) in Singapore, according to a Bloomberg report.
The report said Turmeric capital is now working with advisers on the potential SPAC listing in Singapore even as the city-state has not rolled out its framework for blank-cheque listing.
The SPAC could raise about S$300 million ($221 million). Details are yet to be finalised.
According to a Business Times report, Thakran’s Turmeric Capital is among the three companies that are said to be exploring SPAC listings in Singapore. The other two are Novo Telus Capital Partners and Temasek-backed Vertex.
In February, Thakran filed to raise up to $300 million for his second blank check company, Aspirational Consumer Lifestyle II in the US. That was nearly five months after the first SPAC, Aspirational Consumer Lifestyle, raised around $240 million in an IPO in the US.
In an earlier interview with DealStreetAsia, Thakran said this was the right size to merge with companies that are valued between $1.5 billion and $2.5 billion.
The second SPAC intends to focus on businesses with premium brands that offer an aspirational lifestyle experience to consumers, which the group refers to as “aspirational lifestyle space”.
